Tenofovir use is associated with a decreased risk of hepatocellular carcinoma among men with HIV irrespective of coinfection status

Tenofovir use is associated with a decreased risk of hepatocellular carcinoma among men with HIV irrespective of coinfection status

Background & Aims: Tenofovir is recommended as part of the first-line antiretroviral therapy (ART) to treat people living with HIV (PLWH) with HBV coinfection. However, the effects of tenofovir-containing ART on hepatocellular carcinoma (HCC) risk among PLWH with/without chronic hepatitis vi...

Full description

Bibliographic Details
Main Authors: Mei-Hsuan Lee, Ping-Feng Wu, Tzu-I Chen, Chi Chan, Hsi-Hsun Lin, Yi-Hsiang Huang, Hsuan-Yu Chen, Yi-Tsung Lin, Chien-Jen Chen
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:JHEP Reports
Subjects:
AIDS
chronic hepatitis
risk assessment
nationwide registry
prospective study
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555922002063

Internet

http://www.sciencedirect.com/science/article/pii/S2589555922002063

Similar Items